Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
26.39
+1.86 (7.58%)
Jan 22, 2025, 4:00 PM EST - Market closed
Beam Therapeutics Employees
Beam Therapeutics had 436 employees as of December 31, 2023. The number of employees decreased by 71 or -14.00% compared to the previous year.
Employees
436
Change (1Y)
-71
Growth (1Y)
-14.00%
Revenue / Employee
$801,933
Profits / Employee
-$329,337
Market Cap
2.10B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
BEAM News
- 9 days ago - Beam Therapeutics Announces Progress in Hematology and Genetic Disease Franchises and Outlines Key 2025 Anticipated Catalysts - GlobeNewsWire
- 6 weeks ago - Beam Therapeutics Presents New Non-human Primate (NHP) Data Demonstrating Proof-of-concept for ESCAPE, a Non-genotoxic, Antibody-based Conditioning Approach to Treating Sickle Cell Disease, at American Society of Hematology (ASH) Annual Meeting - GlobeNewsWire
- 6 weeks ago - Beam Therapeutics Announces New Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 in Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting - GlobeNewsWire
- 6 weeks ago - Beam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officer - GlobeNewsWire
- 7 weeks ago - Beam Therapeutics Expands its Board of Directors with Appointment of Chirfi Guindo, Global Biopharma Strategy and Commercial Leader - GlobeNewsWire
- 2 months ago - Beam Therapeutics to Participate in 2024 Jefferies London Healthcare Conference - GlobeNewsWire
- 2 months ago - Beam Therapeutics: Additional BEAM-101 And ESCAPE Tech Data At ASH 2024 Makes This A Watch - Seeking Alpha
- 2 months ago - Beam Therapeutics Inc. (BEAM) Q3 2024 Earnings Call Transcript - Seeking Alpha